Please login to the form below

Not currently logged in
Email:
Password:

cancer drug funding

This page shows the latest cancer drug funding news and features for those working in and with pharma, biotech and healthcare.

Cancer charities criticise NICE's 'last-century methodology'

Cancer charities criticise NICE's 'last-century methodology'

Medical charities in the UK have warned that revised plans for approving cancer drugs will result in fewer being available to patients. ... cancer drugs funding,” said the charity's chief executive Mark Flanagan.

Latest news

  • England's Cancer Drugs Fund: Fixing a broken system England's Cancer Drugs Fund: Fixing a broken system

    Meanwhile, shortly after the de-listing announcement, the Anglo-Swedish firm AstraZeneca said it would not even bother putting its newly approved ovarian cancer drug Lynparza (olaparib) up for funding via ... sustainable solution to cancer drug access

  • Decision to withdraw Jevtana in England ‘flawed’ Decision to withdraw Jevtana in England ‘flawed’

    A UK charity has denounced NHS England's decision to withdraw a new prostate cancer drug from its funding stream. ... It is currently the only treatment for hormone resistant advanced prostate cancer for use after chemotherapy.

  • Philippe Calais appointed CEO of Antisense Pharma

    Philippe Calais appointed CEO of Antisense Pharma. Joins as German biopharma aims to take cancer drug trabedersen to phase I. ... One of his main tasks will be to ensure funding for the development of cancer drug trabedersen, which is planned to start

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Engaging the digital healthcare professional Engaging the digital healthcare professional

    When NICE, the UK policymaker for health spending, rejected Pfizer’s breast cancer drug palbociclib for routine funding on the NHS in February, it tweeted the news and invited comments on ... It was also shared by a student midwife who tweeted to

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics